Minovia Therapeutics
Lea Bensoussan Sebag currently serves as Clinical Trial Manager and Clinical Operation Associate at Minovia Therapeutics since November 2019, where leadership in clinical operations and management of clinical trials has been essential. Previously, at R.G.L Research from December 2016 to November 2019, responsibilities included managing clinical trials and establishing clinical operation strategies. Prior roles involved international headhunting at Pact & Partners International and research-related tasks at various institutions, including optimizing bioengineering processes at CNRS and conducting high-throughput sequencing at Inserm. Lea holds a BioMedical Engineering Master's Degree from Arts et Métiers and a Pharmacy degree from Université Paris Cité, along with GCP certification from The Global Health Network.
Minovia Therapeutics
Minovia Therapeutics is a clinical-stage international biotechnology company, established in hopes to bring life changing therapies to patients with Mitochondrial diseases, as fast as responsible. Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease.